Beam Therapeutics
BEAM
BEAM
205 hedge funds and large institutions have $2.09B invested in Beam Therapeutics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 91 increasing their positions, 45 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $2.82B → $2.09B (-$732M)
35% less call options, than puts
Call options by funds: $11.4M | Put options by funds: $17.5M
54% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 59
Holders
205
Holding in Top 10
3
Calls
$11.4M
Puts
$17.5M
Top Buyers
| 1 | +$52.4M | |
| 2 | +$43.3M | |
| 3 | +$34M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$20.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.7M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$23.8M | |
| 3 | -$17.2M | |
| 4 |
Millennium Management
New York
|
-$6.88M |
| 5 |
CU
CQS (US)
New York
|
-$5.5M |